CY1111650T1 - Ανασυνδυαστικα τροποποιημενη πλασμινη - Google Patents
Ανασυνδυαστικα τροποποιημενη πλασμινηInfo
- Publication number
- CY1111650T1 CY1111650T1 CY20101100930T CY101100930T CY1111650T1 CY 1111650 T1 CY1111650 T1 CY 1111650T1 CY 20101100930 T CY20101100930 T CY 20101100930T CY 101100930 T CY101100930 T CY 101100930T CY 1111650 T1 CY1111650 T1 CY 1111650T1
- Authority
- CY
- Cyprus
- Prior art keywords
- modified plastic
- domain
- terminal
- human plasminogen
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Παρέχονται πολυνουκλεοτίδια και πολυπεπτίδια που συνδέονται με ανασυνδυαστικά τροποποιημένο μόριο πλασμιν(ογόνου). Το μόριο του πλασμιν(ογόνου) έχει μια και μόνο περιοχή kringle στη θέση ενεργοποίησης του Ν-τελικού που είναι παρούσα στο μητρικό μόριο ανθρώπινου πλασμινογόνου και παρουσιάζει σύνδεση με τη λυσίνη και σημαντικά ενζυματικά χαρακτηριστικά που συνδέονται με το μητρικό ένζυμο.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56447204P | 2004-04-22 | 2004-04-22 | |
EP05737862A EP1740698B1 (en) | 2004-04-22 | 2005-04-21 | Recombinantly modified plasmin |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111650T1 true CY1111650T1 (el) | 2015-10-07 |
Family
ID=34982338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100930T CY1111650T1 (el) | 2004-04-22 | 2010-10-18 | Ανασυνδυαστικα τροποποιημενη πλασμινη |
Country Status (28)
Country | Link |
---|---|
US (2) | US8034913B2 (el) |
EP (2) | EP2246417B1 (el) |
JP (1) | JP5026254B2 (el) |
KR (1) | KR101161819B1 (el) |
CN (2) | CN102660564B (el) |
AT (1) | ATE476502T1 (el) |
AU (1) | AU2005238464B2 (el) |
BR (1) | BRPI0510063B8 (el) |
CA (1) | CA2563675C (el) |
CY (1) | CY1111650T1 (el) |
DE (1) | DE602005022692D1 (el) |
DK (1) | DK1740698T3 (el) |
EA (1) | EA010784B1 (el) |
ES (2) | ES2534744T3 (el) |
HK (3) | HK1099341A1 (el) |
HR (1) | HRP20100568T1 (el) |
IL (1) | IL178343A (el) |
MA (1) | MA28590B1 (el) |
MX (1) | MXPA06012236A (el) |
NO (1) | NO338542B1 (el) |
NZ (1) | NZ550250A (el) |
PL (2) | PL1740698T3 (el) |
PT (2) | PT2246417E (el) |
RS (1) | RS51623B (el) |
SI (1) | SI1740698T1 (el) |
TN (1) | TNSN06332A1 (el) |
WO (1) | WO2005105990A2 (el) |
ZA (1) | ZA200608498B (el) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005212431B2 (en) | 2004-02-11 | 2010-07-15 | Synthon Biopharmaceuticals B.V. | Expression of plasminogen and microplasminogen in duckweed |
EP2246417B1 (en) | 2004-04-22 | 2015-01-21 | Grifols Therapeutics Inc. | Recombinantly modified plasmin |
WO2007047874A2 (en) * | 2005-10-20 | 2007-04-26 | Talecris Biotherapeutics, Inc. | Recombinantly modified plasmin |
KR100888022B1 (ko) * | 2006-12-21 | 2009-03-09 | 재단법인 목암생명공학연구소 | 면역글로불린 Fc와 인간 아포리포단백질(a)크링글절편의 융합단백질 LK8Fc |
AU2008331545B2 (en) * | 2007-11-29 | 2014-01-16 | Grifols Therapeutics Inc. | Recombinantly modified plasmin |
EP2297317A4 (en) | 2008-06-04 | 2011-12-07 | Talecris Biotherapeutics Inc | COMPOSITION, METHOD AND NECESSARY FOR THE PREPARATION OF PLASMINE |
HUE025670T2 (en) | 2009-03-03 | 2016-04-28 | Grifols Therapeutics Inc | A method for producing plasminogen |
KR20120050442A (ko) | 2009-07-10 | 2012-05-18 | 쓰롬보제닉스 엔.브이. | 플라스미노겐 및 플라스민의 변이체 |
ES2534911T3 (es) | 2009-08-28 | 2015-04-30 | Thrombogenics N.V. | Uso de plasmina para el tratamiento de fallo de filtración después de trabeculectomía |
CA2823491A1 (en) | 2011-01-05 | 2012-07-12 | Thrombogenics Nv | Plasminogen and plasmin variants |
US9644196B2 (en) | 2011-08-12 | 2017-05-09 | Thrombogenics Nv | Plasminogen and plasmin variants |
CN108463240A (zh) * | 2015-12-18 | 2018-08-28 | 泰伦基国际有限公司 | 一种预防或治疗糖尿病性视网膜病变的方法 |
CN108210895A (zh) * | 2016-12-15 | 2018-06-29 | 深圳瑞健生命科学研究院有限公司 | 预防动脉粥样硬化及其并发症的药物及其用途 |
TW201829448A (zh) | 2016-12-15 | 2018-08-16 | 大陸商深圳瑞健生命科學硏究院有限公司 | 纖溶酶原在製備預防或治療肥胖症及疾病倂發的肥胖的藥物中的用途 |
TWI684459B (zh) | 2016-12-15 | 2020-02-11 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種治療動脈粥樣硬化及其併發症的方法 |
EP3556384B1 (en) | 2016-12-15 | 2024-04-10 | Talengen International Limited | Plasminogen for use in treating diabetes |
EP4137715A4 (en) | 2020-04-13 | 2024-05-01 | Fcc Kk | POWER TRANSMISSION DEVICE |
KR20230005298A (ko) * | 2020-05-11 | 2023-01-09 | 탈렌젠 인터내셔널 리미티드 | 척수성 근위축증의 치료 방법 및 약물 |
AU2021387774A1 (en) | 2020-11-25 | 2023-06-08 | Grifols Worldwide Operations Limited | Wound healing |
US11964004B2 (en) * | 2021-03-31 | 2024-04-23 | Shenzhen Bay Laboratory | Short in vivo half-life and in vivo unstable recombinant microplasmin, pharmaceutical composition comprising thereof and method of treating thromboembolism related diseases including administration thereof |
WO2024018051A1 (en) | 2022-07-22 | 2024-01-25 | Grifols Worldwide Operations Limited | Stable plasmin compositions for organ preservation and reconditioning |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4652639A (en) | 1982-05-06 | 1987-03-24 | Amgen | Manufacture and expression of structural genes |
US4631211A (en) * | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
US5149533A (en) * | 1987-06-04 | 1992-09-22 | Zymogenetics, Inc. | Modified t-PA with kringle-/replaced by another kringle |
US4774087A (en) * | 1987-08-14 | 1988-09-27 | Northwestern University | Micro-size fibrinolytic plasmin |
ES2120949T4 (es) | 1990-06-28 | 2011-12-29 | Sanofi-Aventis Deutschland Gmbh 50% | Proteinas de fusión con porciones de inmunoglobulinas, su preparación y empleo. |
US7253264B1 (en) * | 1990-06-28 | 2007-08-07 | Sanofi-Arentideutschland GmbH | Immunoglobulin fusion proteins, their production and use |
US6613508B1 (en) * | 1996-01-23 | 2003-09-02 | Qiagen Genomics, Inc. | Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
US6312893B1 (en) * | 1996-01-23 | 2001-11-06 | Qiagen Genomics, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
EP0868535B9 (en) | 1996-01-23 | 2007-05-09 | Qiagen Genomics, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
JPH10158300A (ja) * | 1996-11-28 | 1998-06-16 | Suzuki Motor Corp | 血管新生抑制効果を有するタンパク質とその製造方法及びアンギオスタチンの製造方法 |
CN1249252C (zh) | 1997-07-22 | 2006-04-05 | 佳根基因组学公司 | 通过ms使序列数据相关的计算机方法和系统 |
IL140729A0 (en) * | 1998-07-14 | 2002-02-10 | Bristol Myers Squibb Co | Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof |
EP1117437B1 (en) * | 1998-09-29 | 2006-12-27 | Leuven Research & Development vzw | Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
US6969515B2 (en) * | 1999-11-13 | 2005-11-29 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6355243B1 (en) | 1999-11-13 | 2002-03-12 | Bayer Corporation | Method of thrombolysis by local delivery of active plasmin |
US6964764B2 (en) * | 1999-11-13 | 2005-11-15 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6664112B2 (en) * | 2000-06-02 | 2003-12-16 | Blue Heron Biotechnology, Inc. | Methods for improving the sequence fidelity of synthetic double-stranded oligonucleotides |
DE60131450T2 (de) * | 2000-12-21 | 2008-10-16 | Thrombogenics N.V. | Hefeexpressionsvektor und verfahren zur herstellung eines rekombinanten proteins durch expression in einer hefezelle |
WO2003054232A2 (en) | 2001-12-13 | 2003-07-03 | Blue Heron Biotechnology, Inc. | Methods for removal of double-stranded oligonucleotides containing sequence errors using mismatch recognition proteins |
US20050124036A1 (en) * | 2002-02-06 | 2005-06-09 | Rudy Susilo | Method for producing recombinant proteins in micro-organisms |
US7776026B2 (en) * | 2002-02-06 | 2010-08-17 | Nuvue Technologies, Inc. | Method for vitreous liquefaction |
GB0228409D0 (en) | 2002-12-06 | 2003-01-08 | Thromb X Nv | Pharmacological vitreolysis |
EP2246417B1 (en) | 2004-04-22 | 2015-01-21 | Grifols Therapeutics Inc. | Recombinantly modified plasmin |
WO2007047874A2 (en) | 2005-10-20 | 2007-04-26 | Talecris Biotherapeutics, Inc. | Recombinantly modified plasmin |
AU2008331545B2 (en) | 2007-11-29 | 2014-01-16 | Grifols Therapeutics Inc. | Recombinantly modified plasmin |
-
2005
- 2005-04-21 EP EP10166134.6A patent/EP2246417B1/en active Active
- 2005-04-21 DK DK05737862.2T patent/DK1740698T3/da active
- 2005-04-21 JP JP2007509616A patent/JP5026254B2/ja not_active Expired - Fee Related
- 2005-04-21 CN CN2012101142890A patent/CN102660564B/zh not_active Expired - Fee Related
- 2005-04-21 PL PL05737862T patent/PL1740698T3/pl unknown
- 2005-04-21 RS RS20100473A patent/RS51623B/en unknown
- 2005-04-21 ES ES10166134.6T patent/ES2534744T3/es active Active
- 2005-04-21 ES ES05737862T patent/ES2349555T3/es active Active
- 2005-04-21 KR KR1020067024427A patent/KR101161819B1/ko active IP Right Grant
- 2005-04-21 MX MXPA06012236A patent/MXPA06012236A/es active IP Right Grant
- 2005-04-21 CN CNA2005800155389A patent/CN1961070A/zh active Pending
- 2005-04-21 DE DE602005022692T patent/DE602005022692D1/de active Active
- 2005-04-21 PT PT101661346T patent/PT2246417E/pt unknown
- 2005-04-21 CA CA2563675A patent/CA2563675C/en active Active
- 2005-04-21 EA EA200601950A patent/EA010784B1/ru not_active IP Right Cessation
- 2005-04-21 BR BRPI0510063A patent/BRPI0510063B8/pt not_active IP Right Cessation
- 2005-04-21 AU AU2005238464A patent/AU2005238464B2/en not_active Ceased
- 2005-04-21 PL PL10166134T patent/PL2246417T3/pl unknown
- 2005-04-21 WO PCT/US2005/013562 patent/WO2005105990A2/en active Application Filing
- 2005-04-21 NZ NZ550250A patent/NZ550250A/en not_active IP Right Cessation
- 2005-04-21 US US11/568,023 patent/US8034913B2/en not_active Expired - Fee Related
- 2005-04-21 EP EP05737862A patent/EP1740698B1/en active Active
- 2005-04-21 PT PT05737862T patent/PT1740698E/pt unknown
- 2005-04-21 AT AT05737862T patent/ATE476502T1/de active
- 2005-04-21 SI SI200531131T patent/SI1740698T1/sl unknown
-
2006
- 2006-09-27 IL IL178343A patent/IL178343A/en active IP Right Grant
- 2006-10-11 ZA ZA200608498A patent/ZA200608498B/en unknown
- 2006-10-13 TN TNP2006000332A patent/TNSN06332A1/en unknown
- 2006-11-03 NO NO20065050A patent/NO338542B1/no not_active IP Right Cessation
- 2006-11-20 MA MA29466A patent/MA28590B1/fr unknown
-
2007
- 2007-06-15 HK HK07106503.0A patent/HK1099341A1/xx not_active IP Right Cessation
-
2010
- 2010-10-18 CY CY20101100930T patent/CY1111650T1/el unknown
- 2010-10-19 HR HR20100568T patent/HRP20100568T1/hr unknown
-
2011
- 2011-04-28 HK HK11104278.2A patent/HK1150242A1/xx not_active IP Right Cessation
- 2011-09-01 US US13/223,373 patent/US8420079B2/en active Active
-
2013
- 2013-03-12 HK HK13103040.9A patent/HK1175812A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111650T1 (el) | Ανασυνδυαστικα τροποποιημενη πλασμινη | |
NZ593837A (en) | Recombinantly modified plasmin | |
MY148447A (en) | Method for amidating polypeptides with basic aminoacid d-terminals by means of specific endoproteases | |
BRPI0606612A2 (pt) | expressão recombinante de proteìnas em uma forma de duas cadeias ligadas por dissulfeto | |
EA200901430A1 (ru) | Варианты фермента аспарагиназы и их применение | |
WO2007016476A3 (en) | Hepatitis c serine protease inhibitors and uses therefor | |
EA201001881A1 (ru) | Пролинспецифичная протеаза из penicillium chrysogenum | |
ATE350470T1 (de) | Durch thrombin spaltbare chimäre proteine | |
WO2007047874A3 (en) | Recombinantly modified plasmin | |
ATE548380T1 (de) | Mutante des hgf-precursor-proteins und aktivierte form davon | |
DE59711957D1 (de) | Rekombinante blutgerinnungsproteasen | |
Hahn et al. | Purification and characterization of a serine protease with fibrinolytic activity from Tenodera sinensis (praying mantis) | |
ATE309363T1 (de) | Hybrid-toxine von bacillus thuringiensis | |
HUP0400458A2 (hu) | Kobalaminkötő fehérjéket expresszáló transzgenikus növények | |
Castro et al. | Current status of snake venom thrombin-like enzymes | |
EE05296B1 (et) | Glkuronl-C5-epimeraas, seda kodeeriv DNA ja selle kasutamine | |
NO20082864L (no) | Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav | |
Oyama et al. | Amino acid sequence of a thrombin like enzyme, elegaxobin II, from the venom of Trimeresurus elegans (Sakishima-Habu) | |
DE602004029345D1 (de) | Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper |